SCHEMBL28039017

SCHEMBL28039017

COc1c(Cl)cc(C(F)(F)F)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
HPGD P15428 4/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
TP53 P04637 1/20 0.41
ALDH1A1 P00352 4/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C19 P33261 2/20 0.40
GAA P10253 2/20 0.40
CYP2C9 P11712 1/20 0.40
PDE2A O00408 1/20 0.40
ACLY P53396 1/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
GPR35 Q9HC97 1/20 0.40
MAPK1 P28482 1/20 0.39
PTGS2 P35354 1/20 0.39
NPBWR1 P48145 1/20 0.38
MCHR1 Q99705 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13855826 0.90 PTGS2 (0.39) KDM4EHPGDLMNAMAPTTP53
SCHEMBL14201636 0.88 KDM4E (0.38) KDM4EHPGDLMNAMAPTTP53
SCHEMBL8154080 0.86 CYP1A2 (0.43) KDM4EHPGDLMNAMAPTTP53
SCHEMBL14613173 0.83 GABRB3 (0.39) KDM4EHPGDLMNAMAPTTP53
SCHEMBL16005511 0.82 KDM4E (0.38) KDM4EHPGDLMNAMAPTTP53
SCHEMBL27260206 0.81 PDE2A (0.38) KDM4EHPGDALDH1A1CYP1A2CYP3A4
SCHEMBL21999697 0.80 ACLY (0.48) KDM4EHPGDLMNAMAPTTP53
SCHEMBL8709761 0.80 GAA (0.43) KDM4EHPGDLMNAMAPTTP53
SCHEMBL8162628 0.79 TDP1 (0.60) HPGDLMNAMAPTALDH1A1CYP1A2
SCHEMBL11609176 0.79 ALDH1A1 (0.41) KDM4EHPGDLMNAALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103097364-B Spiro-piperidine derivatives as S1P modulators ABBOTT HEALTHCARE PRODUCTS B.V. (NL) 2015-11-25 CN disclosed